For the Quarter Ending June 2026
Levetiracetam Prices in North America
- In the USA, the Levetiracetam Price Index rose by 12.33% quarter-over-quarter, driven by recent freight increases.
- The average Levetiracetam price for the quarter was approximately USD 32072.33/MT, reflecting import parity and logistics-driven cost components.
- Levetiracetam Spot Price firmed as container freight surged, supporting higher Los Angeles CFR offers consistently.
- Levetiracetam Production Cost Trend skewed higher due to feedstock and insurance premiums affecting Asian synthesis.
- Levetiracetam Demand Outlook remains steady as prescriptions grow, sustaining importers' absorption of higher landed costs.
- Levetiracetam Price Forecast projects modest CFR increases as logistics pressures persist and inventories remain lean.
- Levetiracetam Price Index volatility moderated despite monthly freight shocks and steady downstream procurement activity levels.
- Indian and Chinese plants ran routine campaigns, export allocations constrained by inspections and shipping congestion.
Why did the price of Levetiracetam change in June 2026 in North America?
- Shanghai-Houston freight surged, adding high landed cost and directly pushing CFR offers higher in June.
- Post-inspection remediation limited Indian export allocations while rupee depreciation raised dollar-denominated import parities, increasing pressure.
- Steady neurology prescriptions and hospital restocking maintained offtake, allowing importers to pass through higher costs.
Levetiracetam Prices in APAC
- In China, the Levetiracetam Price Index rose by 12.14% quarter-over-quarter, reflecting stronger export bookings overall.
- The average Levetiracetam price for the quarter was USD 31900/MT, based on Shanghai FOB assessments.
- Tight inventories and steady exports supported the Levetiracetam Spot Price, sustaining seller confidence through June.
- Stable feedstock availability kept the Levetiracetam Production Cost Trend contained despite seasonal electricity tariff increases.
- Levetiracetam Demand Outlook remained constructive as European and US formulators continued forward purchases, sustaining export momentum.
- Short-term Levetiracetam Price Forecast indicates gains ahead, driven by consistent international procurement and controlled supply.
- Compliance inspections trimmed mid-tier output, which tightened Levetiracetam Price Index movements and reduced available spot volumes.
- Bonded warehouse inventories remained below seasonal norms, amplifying sellers' pricing power across FOB export allocations.
Why did the price of Levetiracetam change in June 2026 in APAC?
- Stronger export bookings outpaced modest supply increases, tightening immediate availability and supporting FOB quotations in June.
- Environmental inspections temporarily curtailed mid-tier production, reducing merchant market volumes and lifting short-term price pressure.
- War-driven petrochemical and logistics cost inflation prompted buyers to build safety stocks with Chinese suppliers.
India
- In India, the Levetiracetam Price Index rose by 7.49% quarter-over-quarter, driven by feedstock costs.
- Levetiracetam Spot Price firmed in June as customs delays tightened intermediate supplies, reducing prompt availability.
Levetiracetam Prices in Europe
- In Germany, the Levetiracetam Price Index rose by 12.22% quarter-over-quarter, driven by higher import costs.
- The average Levetiracetam price for the quarter was approximately USD 32047/MT based on CFR Hamburg data.
- Levetiracetam Spot Price firmed on hospital restocking, supporting the broader Levetiracetam Price Index near-term trend.
- Market models in Germany align with the Levetiracetam Price Forecast indicating modest gains through the third quarter.
- Rising European gas tariffs and solvent levies influenced the Levetiracetam Production Cost Trend, tightening supplier margins.
- Levetiracetam Demand Outlook remains steady as an ageing population and hospital tender schedules support pharmaceutical offtake.
- Comfortable inventories in Hamburg limited tightness, but parallel export flow and hospital restocking supported the Price Index.
- Major Indian, Spanish and Italian producers ran normal campaigns, preserving arrivals, stabilizing Levetiracetam Spot Price.
- Geopolitical tensions elevated freight premiums and insurance, feeding into landed costs and reinforcing pressure on the Price Index.
Why did the price of Levetiracetam change in June 2026 in Europe?
- Currency depreciation increased dollar-denominated landed costs, directly lifting CFR offers for German importers in June.
- Hospital tender front-loading tightened prompt availability, elevating short-term demand and supporting stronger spot quotations overall.
- Higher gas tariffs and solvent levies raised production expenses, narrowing supplier margins and lifting CFR prices.
For the Quarter Ending March 2026
Levetiracetam Prices in North America
- In the USA, the Levetiracetam Price Index rose by 6.01% quarter-over-quarter, reflecting tighter imports and higher freight.
- The average Levetiracetam price for the quarter was approximately USD 28552.33/MT, reflecting modest supply tightness.
- March registered a Levetiracetam Spot Price rise as freight and prioritised orders tightened US allocations.
- Levetiracetam Production Cost Trend showed higher landed costs as Trans-Pacific freight and feedstock inflation rose.
- Levetiracetam Demand Outlook remains steady with approximately three million patients and prescription growth sustaining baseline consumption.
- Inventories were overall adequate, so the Levetiracetam Price Index stayed firm amid balanced distributor holdings.
- Analysts expect the Levetiracetam Price Forecast to reflect freight swings and exporter prioritisation of demand.
- Competitor bidding and payer formularies limited pass-through, tempering spot offers, and moderating Levetiracetam Spot Price volatility.
Why did the price of Levetiracetam change in March 2026 in North America?
- Trans-Pacific freight rose significantly, raising landed costs and directly increasing CFR Los Angeles import prices.
- Indian and Chinese exporters prioritised higher-margin regional orders, reducing volumes available for United States buyers.
- Domestic formulary changes expanded Tier-6 coverage, boosting prescriptions and supporting suppliers in passing increased costs.
Levetiracetam Prices in APAC
- In China, the Levetiracetam Price Index rose by 6.01% quarter-over-quarter, driven by tightened export availability and buying.
- The average Levetiracetam price for the quarter was approximately USD 28447.33/MT across FOB Shanghai shipments.
- Levetiracetam Spot Price strengthened as inventories fell below two weeks, prompting sellers to lift offers.
- Levetiracetam Price Forecast indicates softening after March surge as export enquiries moderate and inventories rebuild.
- Levetiracetam Production Cost Trend rose due to firmer pyrrolidone and -butyrolactone prices, narrowing conversion margins.
- Levetiracetam Demand Outlook remains export-driven with continued US and European tender reallocation supporting near-term volumes.
- Levetiracetam Price Index volatility increased as environmental inspections tightened supply while exporters prioritized contract shipments.
- Logistics risk from Strait of Hormuz disruptions raised freight premiums, influencing seller offers and contract lead times.
Why did the price of Levetiracetam change in March 2026 in APAC?
- Late-February and March environmental enforcement actions forced mid-scale plants to pause, materially reducing exportable supply.
- Firmer pyrrolidone and -butyrolactone feedstock prices increased conversion costs, allowing producers to lift FOB offers.
- Accelerated overseas purchases, prompted by regulatory actions against Indian suppliers, significantly boosted Chinese export demand.
Levetiracetam Prices in Europe
- In Germany, the Levetiracetam Price Index rose by 6.08% quarter-over-quarter, driven by tighter cargo allocations.
- The average Levetiracetam price for the quarter was approximately USD 28557.33/MT, reflecting mixed monthly movements.
- Levetiracetam Spot Price firmed amid constrained allocations, with higher freight and elevated landed costs pressuring offers.
- Levetiracetam Price Forecast indicates short-term firmness as buyers secure forward volumes ahead of spring tenders.
- Levetiracetam Production Cost Trend showed pressure from higher ocean freight and insurance surcharges, nudging FOB quotations.
- Levetiracetam Demand Outlook remains steady with ageing population-driven prescriptions and hospital restocking supporting baseline consumption.
- Levetiracetam Price Index reflected parallel-trade outflows tightening local inventories, limiting downside despite modest demand growth.
- Major exporters maintained campaigns but diverted volumes to higher-margin markets, tightening European CFR availability and allotments.
Why did the price of Levetiracetam change in March 2026 in Europe?
- Tighter cargo availability from India and Spain reduced spot allocations, increasing competition for inbound cargoes.
- Higher ocean freight surcharges and conflict-linked insurance costs raised landed costs, pushing parity offers upward.
- Restocking by wholesalers and hospital buying ahead of tenders increased immediate demand, tightening short-term availability.
For the Quarter Ending December 2025
APAC
- In China, the Levetiracetam Price Index fell by 0.77% quarter-over-quarter, reflecting softer export inquiries globally.
- The average Levetiracetam price for the quarter was approximately USD 26833.33/MT reflecting FOB Shanghai quarterly billing levels.
- Levetiracetam Spot Price showed limited spot activity as exporters trimmed offers to allocate cargoes before holidays.
- Levetiracetam Price Forecast indicates modest volatility with cautious seller offers and measured international restocking demand.
- Levetiracetam Production Cost Trend remained benign with stable feedstock supply and no significant coal tariff pressure.
- Levetiracetam Demand Outlook was stronger for export markets while domestic procurement shifted to measured replenishment.
- Levetiracetam Price Index reflected marginal quarterly weakness amid ample inventories and steady plant operating rates.
- Market logistics and currency movements supported Chinese FOB competitiveness, constraining upward pricing pressure despite firm margins.
Why did the price of Levetiracetam change in December 2025 in APAC?
- Export inquiries thinned after buyers completed tender cycles, reducing spot purchase urgency and lowering offers.
- Stable feedstock availability, uninterrupted plant output kept conversion costs subdued, limiting cost pressure on FOB.
- Year-end inventory positions and pragmatic distributor purchasing reduced demand, prompting sellers to trim prices slightly.
Europe
- In Germany, the Levetiracetam Price Index fell by 0.69% quarter-over-quarter, reflecting normalized imports and eased freight.
- The average Levetiracetam price for the quarter was approximately USD 350175.00/MT, per assessed CFR Hamburg transactions.
- Levetiracetam Spot Price remained subdued amid ample Indian and Spanish cargoes, enabling buyers to negotiate lower landed terms.
- Levetiracetam Price Forecast signals modest recovery into early 2026 driven by restocking and steady pharmaceutical procurement.
- Levetiracetam Production Cost Trend showed limited upward pressure due to contained acetonitrile and stable Asian natural gas inputs.
- Levetiracetam Demand Outlook remains stable driven by ageing demographics and hospital restocking ahead of tender cycles.
- Levetiracetam Price Index softness reflected rising distributor inventories and disciplined exporter offers from India and Spain.
- Hamburg port efficiency and steady EUR-USD parity reduced landed cost volatility, constraining abrupt Levetiracetam Price Index movements.
Why did the price of Levetiracetam change in December 2025 in Europe?
- Ample exports from India and Spain kept supply abundant, preventing year-end buying and pressuring CFR quotations lower.
- Stable EUR-USD exchange and contained freight costs limited landed-cost inflation, reducing upward pressure on German buyers.
- No reported plant outages and balanced inventories led distributors to avoid aggressive restocking, sustaining mildly bearish sentiment.
North America
- In USA, Levetiracetam Price Index fell by 0.68% quarter-over-quarter, reflecting eased freight and normalized exports.
- The average Levetiracetam price for the quarter was approximately USD 350185.00/MT, and reflecting balanced inventories.
- Levetiracetam Spot Price softened as competitive generic bids and ample Asian inventories pressured CFR offers.
- Levetiracetam Price Forecast suggests mild volatility with modest restocking, importer discipline, and cautious phased procurement.
- Levetiracetam Production Cost Trend showed limited upward pressure as freight declines offset persistent feedstock inflation.
- Levetiracetam Demand Outlook remains stable, supported by steady prescriptions, formulary positioning, and predictable downstream offtake.
- Levetiracetam Price Index movements were modest, influenced by port efficiencies, tariff truce, and regulatory environment.
- Balanced imports, comfortable coastal inventories, and selective restocking are expected to govern CFR pricing dynamics.
Why did the price of Levetiracetam change in December 2025 in North America?
- Reduced China-to-USA freight rates trimmed landed costs in December, enabling importers to lower CFR quotations.
- Intense year-end generic bidding compressed margins, prompting sellers to concede modest discounts for calendar contracts.
- Comfortable distributor inventories and predictable prescription demand reduced urgency, limiting spot buying and upward pressure.
For the Quarter Ending September 2025
North America
- In the USA, the Levetiracetam Price Index rose by 2.45% quarter-over-quarter, driven by higher import costs and steady downstream demand.
- The average Levetiracetam price for the quarter was approximately USD 30263.33/MT, reflecting elevated import and freight costs.
- Levetiracetam Spot Price showed intramonth volatility as Chinese offers and freight variations altered landed procurement economics.
- Levetiracetam Price Forecast indicates modest upward bias due to restocking, firm pharmaceutical demand, and constrained export availability.
- Levetiracetam Production Cost Trend reflects higher Asian export offers and freight, supporting seller pricing power despite stable manufacturing.
- Levetiracetam Demand Outlook remains constructive from API producers and formulators, underpinning firm offtake into the quarter.
- Elevated inventories intermittently pressured the Levetiracetam Price Index, but strategic restocking maintained transactional momentum among distributors.
- Export demand and operational status of major suppliers influenced offers, with small supply disruptions tightening selective regional availability.
Why did the price of Levetiracetam change in September 2025 in North America?
- Higher import costs and freight increases raised landed costs, pressuring domestic procurement margins and offers.
- Tightening export offers from Asian suppliers reduced availability, prompting urgent restocking and stronger seller pricing.
- Elevated domestic inventories and cautious buyer behaviour limited spot buying, moderating momentum despite cost pressures.
APAC
- In China, the Levetiracetam Price Index rose by 2.83% quarter-over-quarter, driven by tight inventories recently.
- The average Levetiracetam price for the quarter was approximately USD 30233.33/MT on FOB Shanghai basis.
- Levetiracetam Spot Price strengthened amid flood-induced plant closures and accelerated restocking by overseas buyers recently.
- Levetiracetam Price Forecast points to modest gains as sustained export enquiries offset intermittent production restarts.
- Levetiracetam Production Cost Trend shows upward pressure from higher logistics and raw material expenses affecting margins.
- Levetiracetam Demand Outlook remains constructive with steady pharmaceutical offtake and renewed international procurement interest emerging.
- Levetiracetam Price Index volatility reflected seasonal shutdowns, inventory swings, currency effects and targeted supplier discounting.
- Major plant disruptions and subsequent restarts constrained availability, influencing exports, inventories and transactional Levetiracetam pricing dynamics.
Why did the price of Levetiracetam change in September 2025 in APAC?
- Resumption of production in August increased supply while July flood damage previously tightened availability materially.
- Elevated inventories and subdued overseas procurement in August reduced buying urgency, pressuring spot pricing downward.
- Currency movements and logistics costs altered export margins, prompting exporters to adjust offers and profitability.
Europe
- In Germany, the Levetiracetam Price Index rose by 2.64% quarter-over-quarter, driven by higher import costs.
- The average Levetiracetam price for the quarter was approximately USD 30270.67/MT, according to CFR Hamburg data.
- Levetiracetam Spot Price softened as Asian exporters eased offers and domestic inventories remained elevated recently.
- Levetiracetam Price Forecast indicates mild recovery ahead, supported by restocking and steady pharmaceutical procurement activity.
- Levetiracetam Production Cost Trend showed upward pressure from freight increases and higher Asian producer offers.
- Levetiracetam Demand Outlook remains positive due to stronger German pharmaceutical manufacturing and new order volumes.
- Levetiracetam Price Index volatility eased as freight stabilized, but buyers remained cautious on bulk replenishment.
- Inventory levels remained high, export demand softened, while major suppliers reported steady rates and availability.
Why did the price of Levetiracetam change in September 2025 in Europe?
- Reduced import costs and eased Asian offers lowered landed procurement expenses, pressuring domestic quotations further.
- Elevated German inventories and cautious buyer behaviour limited fresh orders, weakening demand and transactional volumes.
- Earlier high freight charges increased landed costs, though subsequent freight stabilization eased import cost pressures.
